{"id":"beclamide","rwe":[],"tags":[{"label":"beclamide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"N03AX30","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"nydran","offLabel":[],"synonyms":["beclamide","beclamid","beklamid","chloracon","chlorakon","chloroethylphenamide","neuracen","nidrane","nydran","nydrane"],"timeline":[],"brandName":"Nydran","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"beclamide","explanation":"Imagine your body's cells are like a factory, and enzymes are the workers that help things get done. Beclamide is like a tool that tries to stop one of those workers from doing its job, but we're not entirely sure which worker it is or how it does it. This can help slow down or stop certain processes in the body that might be contributing to a disease or condition.","oneSentence":"Beclamide is thought to work by inhibiting a specific enzyme or protein, but the exact details of its mechanism are not well understood.","technicalDetail":"Beclamide is a small molecule inhibitor that may target a specific enzyme or protein, but the exact molecular details of its mechanism are not well-documented."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/291","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BECLAMIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:57:17.964041","biosimilars":[],"competitors":[{"drugName":"phenacemide","drugSlug":"phenacemide","fdaApproval":"1951-06-28","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"lamotrigine","drugSlug":"lamotrigine","fdaApproval":"1994-12-27","patentExpiry":"May 29, 2040","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"felbamate","drugSlug":"felbamate","fdaApproval":"1993-07-29","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"topiramate","drugSlug":"topiramate","fdaApproval":"1996-12-24","patentExpiry":"Nov 16, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"levetiracetam","drugSlug":"levetiracetam","fdaApproval":"1999-11-30","patentExpiry":"Sep 3, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"zonisamide","drugSlug":"zonisamide","fdaApproval":"2000-03-27","patentExpiry":"Aug 18, 2038","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"stiripentol","drugSlug":"stiripentol","fdaApproval":"2018-08-20","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"lacosamide","drugSlug":"lacosamide","fdaApproval":"2008-10-28","patentExpiry":"Jun 5, 2040","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"retigabine","drugSlug":"retigabine","fdaApproval":"2011-06-10","relationship":"same-class"},{"drugName":"perampanel","drugSlug":"perampanel","fdaApproval":"2012-10-22","patentExpiry":"Jul 1, 2026","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"brivaracetam","drugSlug":"brivaracetam","fdaApproval":"2016-02-18","patentExpiry":"Feb 21, 2026","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"cannabidiol","drugSlug":"cannabidiol","fdaApproval":"2018-06-25","patentExpiry":"Oct 13, 2035","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"cenobamate","drugSlug":"cenobamate","fdaApproval":"2019-11-21","patentExpiry":"Oct 30, 2032","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"fenfluramine","drugSlug":"fenfluramine","fdaApproval":"2020-06-25","patentExpiry":"Nov 3, 2033","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"ganaxolone","drugSlug":"ganaxolone","fdaApproval":"2022-03-18","patentExpiry":"Sep 30, 2042","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"beclamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"phenacemide","brandName":"phenacemide","genericName":"phenacemide","approvalYear":"1951","relationship":"same-class"},{"drugId":"lamotrigine","brandName":"lamotrigine","genericName":"lamotrigine","approvalYear":"1994","relationship":"same-class"},{"drugId":"felbamate","brandName":"felbamate","genericName":"felbamate","approvalYear":"1993","relationship":"same-class"},{"drugId":"topiramate","brandName":"topiramate","genericName":"topiramate","approvalYear":"1996","relationship":"same-class"},{"drugId":"levetiracetam","brandName":"levetiracetam","genericName":"levetiracetam","approvalYear":"1999","relationship":"same-class"},{"drugId":"zonisamide","brandName":"zonisamide","genericName":"zonisamide","approvalYear":"2000","relationship":"same-class"},{"drugId":"stiripentol","brandName":"stiripentol","genericName":"stiripentol","approvalYear":"2018","relationship":"same-class"},{"drugId":"lacosamide","brandName":"lacosamide","genericName":"lacosamide","approvalYear":"2008","relationship":"same-class"},{"drugId":"retigabine","brandName":"retigabine","genericName":"retigabine","approvalYear":"2011","relationship":"same-class"},{"drugId":"perampanel","brandName":"perampanel","genericName":"perampanel","approvalYear":"2012","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"F5N0ALI65V","CHEBI":"CHEBI:134859","INN_ID":"823","RXNORM":"18846","UMLSCUI":"C0053067","ChEMBL_ID":"CHEMBL64195","KEGG_DRUG":"D07300","DRUGBANK_ID":"DB09011","PUBCHEM_CID":"10391","SNOMEDCT_US":"322860003","MESH_SUPPLEMENTAL_RECORD_UI":"C011676"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":17,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"N03AX30","allCodes":["N03AX30"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nydran (Beclamide) is a small molecule drug in the beclamide class, but its target and exact mechanism of action are unknown. It is not clear if it is FDA-approved or commercially available. Beclamide is a type of medication that may be used to treat certain conditions, but its specific indications are not well-documented. The commercial status of Nydran is also unclear, and it may be patented or available as a generic medication. Further research is needed to understand the safety and efficacy of Nydran.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}